Literature DB >> 9806902

An aggrecan-degrading activity associated with chondrocyte membranes.

C J Billington1, I M Clark, T E Cawston.   

Abstract

The breakdown of aggrecan in cartilage is, in part, mediated by an enzyme named aggrecanase that cleaves within the interglobular domain of the molecule between a glutamic residue and an alanine residue. Although the enzyme cleavage site has been identified, the identity, characteristics and localization of this enzyme remain unclear. We have demonstrated that membranes isolated from stimulated chondrocytes are able to generate aggrecan fragments that are labelled by an antibody that recognizes the new N-terminus formed by aggrecanase activity. It was further shown that the membrane activity was a metalloproteinase but was not inhibited by the naturally occurring matrix metalloproteinase (MMP) inhibitors, TIMPs 1 and 2. These results show that an aggrecanase activity is associated with the membranes of the chondrocytes and is a metalloproteinase, but might not be a member of the MMP family.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9806902      PMCID: PMC1219859          DOI: 10.1042/bj3360207

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  30 in total

1.  Expression of members of a novel membrane linked metalloproteinase family (ADAM) in human articular chondrocytes.

Authors:  N McKie; T Edwards; D J Dallas; A Houghton; B Stringer; R Graham; G Russell; P I Croucher
Journal:  Biochem Biophys Res Commun       Date:  1997-01-13       Impact factor: 3.575

Review 2.  Membrane protein secretases.

Authors:  N M Hooper; E H Karran; A J Turner
Journal:  Biochem J       Date:  1997-01-15       Impact factor: 3.857

3.  The structure of aggrecan and its turnover in cartilage.

Authors:  T E Hardingham; A J Fosang
Journal:  J Rheumatol Suppl       Date:  1995-02

Review 4.  Anabolic and catabolic markers of proteoglycan metabolism in osteoarthritis.

Authors:  B Caterson; C E Hughes; P Roughley; J S Mort
Journal:  Acta Orthop Scand Suppl       Date:  1995-10

5.  Cleavage of native cartilage aggrecan by neutrophil collagenase (MMP-8) is distinct from endogenous cleavage by aggrecanase.

Authors:  E C Arner; C P Decicco; R Cherney; M D Tortorella
Journal:  J Biol Chem       Date:  1997-04-04       Impact factor: 5.157

6.  Neutrophil collagenase (MMP-8) cleaves at the aggrecanase site E373-A374 in the interglobular domain of cartilage aggrecan.

Authors:  A J Fosang; K Last; P J Neame; G Murphy; V Knäuper; H Tschesche; C E Hughes; B Caterson; T E Hardingham
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

7.  Interleukin-1 and oncostatin M in combination promote the release of collagen fragments from bovine nasal cartilage in culture.

Authors:  T E Cawston; A J Ellis; G Humm; E Lean; D Ward; V Curry
Journal:  Biochem Biophys Res Commun       Date:  1995-10-04       Impact factor: 3.575

8.  Cell-mediated catabolism of aggrecan. Evidence that cleavage at the "aggrecanase" site (Glu373-Ala374) is a primary event in proteolysis of the interglobular domain.

Authors:  M W Lark; J T Gordy; J R Weidner; J Ayala; J H Kimura; H R Williams; R A Mumford; C R Flannery; S S Carlson; M Iwata
Journal:  J Biol Chem       Date:  1995-02-10       Impact factor: 5.157

9.  Degradation of cartilage aggrecan by collagenase-3 (MMP-13).

Authors:  A J Fosang; K Last; V Knäuper; G Murphy; P J Neame
Journal:  FEBS Lett       Date:  1996-02-12       Impact factor: 4.124

10.  Structural interaction of natural and synthetic inhibitors with the venom metalloproteinase, atrolysin C (form d).

Authors:  D Zhang; I Botos; F X Gomis-Rüth; R Doll; C Blood; F G Njoroge; J W Fox; W Bode; E F Meyer
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

View more
  10 in total

1.  Presentation of the candidate rheumatoid arthritis autoantigen aggrecan by antigen-specific B cells induces enhanced CD4(+) T helper type 1 subset differentiation.

Authors:  Caroline L Wilson; Dominic W Hine; Ariel Pradipta; Jeffrey P Pearson; Willem van Eden; John H Robinson; Andrew M Knight
Journal:  Immunology       Date:  2012-04       Impact factor: 7.397

2.  Interleukin 13 blocks the release of collagen from bovine nasal cartilage treated with proinflammatory cytokines.

Authors:  C S Cleaver; A D Rowan; T E Cawston
Journal:  Ann Rheum Dis       Date:  2001-02       Impact factor: 19.103

3.  Esculetin inhibits cartilage resorption induced by interleukin 1alpha in combination with oncostatin M.

Authors:  S Elliott; A D Rowan; S Carrère; P Koshy; J B Catterall; T E Cawston
Journal:  Ann Rheum Dis       Date:  2001-02       Impact factor: 19.103

4.  Oncostatin M in combination with tumour necrosis factor {alpha} induces a chondrocyte membrane associated aggrecanase that is distinct from ADAMTS aggrecanase-1 or -2.

Authors:  W Hui; H E Barksby; D A Young; T E Cawston; N McKie; A D Rowan
Journal:  Ann Rheum Dis       Date:  2005-05-05       Impact factor: 19.103

5.  Link peptide cartilage growth factor is degraded by membrane proteinases.

Authors:  M F Dean; P Sansom
Journal:  Biochem J       Date:  2000-07-15       Impact factor: 3.857

Review 6.  The clinical potential of matrix metalloproteinase inhibitors in the rheumatic disorders.

Authors:  S Elliott; T Cawston
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

7.  Adenoviral gene transfer of interleukin-1 in combination with oncostatin M induces significant joint damage in a murine model.

Authors:  Andrew D Rowan; Wang Hui; Tim E Cawston; Carl D Richards
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

8.  Microvesicles shed by oligodendroglioma cells and rheumatoid synovial fibroblasts contain aggrecanase activity.

Authors:  Alessandra Lo Cicero; Iwona Majkowska; Hideaki Nagase; Italia Di Liegro; Linda Troeberg
Journal:  Matrix Biol       Date:  2012-03-03       Impact factor: 11.583

9.  Fibroblast activation protein alpha is expressed by chondrocytes following a pro-inflammatory stimulus and is elevated in osteoarthritis.

Authors:  Jennifer M Milner; Lara Kevorkian; David A Young; Debra Jones; Robin Wait; Simon T Donell; Emma Barksby; Angela M Patterson; Jim Middleton; Benjamin F Cravatt; Ian M Clark; Andrew D Rowan; Timothy E Cawston
Journal:  Arthritis Res Ther       Date:  2006-01-03       Impact factor: 5.156

Review 10.  Articular cartilage and changes in arthritis: matrix degradation.

Authors:  J S Mort; C J Billington
Journal:  Arthritis Res       Date:  2001-09-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.